Courcouronnes, France

Lorène Telot

This inventor holds 1 USPTO granted patent. Top assignee: Abolis Biotechnologies. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorène Telot. Retrieved from https://idiyas.com/inventor/lorène-telot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorène Telot: Innovator in Biotechnologies

Introduction

Lorène Telot is a notable inventor based in Courcouronnes, France. She has made significant contributions to the field of biotechnology, particularly in the production of valuable compounds through innovative methods.

Latest Patents

Lorène holds a patent for a "Recombinant Yeast Capable of Producing Caffeic Acid and/or Ferulic Acid." This invention showcases her expertise in utilizing yeast for the production of important biochemical compounds, which have various applications in food, cosmetics, and pharmaceuticals.

Career Highlights

Lorène Telot is currently associated with Abolis Biotechnologies, a company that focuses on developing biotechnological solutions. Her work at Abolis has positioned her as a key player in the advancement of biotechnological innovations.

Collaborations

She collaborates with talented individuals such as Clémentine Fojcik and André Le Jeune, contributing to a dynamic team that drives research and development in the field.

Conclusion

Lorène Telot's innovative work in biotechnology, particularly her patent on recombinant yeast, highlights her significant role in advancing the industry. Her contributions are paving the way for future developments in biotechnological applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…